Heron Therapeutics
HRTX
#8077
Rank
HK$1.42 B
Marketcap
HK$9.41
Share price
-5.47%
Change (1 day)
119.21%
Change (1 year)

P/E ratio for Heron Therapeutics (HRTX)

P/E ratio as of November 2024 (TTM): -1.03

According to Heron Therapeutics's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -1.03419. At the end of 2022 the company had a P/E ratio of -1.45.

P/E ratio history for Heron Therapeutics from 2001 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-1.45-64.39%
2021-4.06-52.08%
2020-8.47-9.91%
2019-9.40-10.49%
2018-10.5112.94%
2017-4.9371.3%
2016-2.88-68.3%
2015-9.08160.89%
2014-3.4833.44%
2013-2.61-57.31%
2012-6.11248.86%
2011-1.75-29.93%
2010-2.50-36.51%
2009-3.94603.13%
2008-0.560055.6%
2007-0.3599-76.09%
2006-1.51-67.53%
2005-4.6418.02%
2004-3.93-66.33%
2003-11.7296.67%
2002-2.94-86.34%
2001-21.5

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
22.5-2,274.87%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
118-11,461.55%๐Ÿ‡บ๐Ÿ‡ธ USA
-0.7853-24.07%๐Ÿ‡บ๐Ÿ‡ธ USA
77.8-7,618.73%๐Ÿ‡บ๐Ÿ‡ธ USA
-23.1 2,136.85%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.